Simplex Trading’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
SFM
BH
AC
VCM
RA
WCM
BAM
Simplex Trading's ANGO Position: Q1 2026 in Review
Simplex Trading sold out of AngioDynamics (ANGO) in Q1 2026, closing a stake of 3,266 shares — an estimated $35.4K sold.
Simplex Trading first reported a position in ANGO in Q4 2014 and held it in 18 quarters. The position peaked at $100K in Q2 2025. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.
- Simplex Trading reported no remaining AngioDynamics position as of Q1 2026 after selling out during the quarter.
- Simplex Trading sold 3,266 AngioDynamics shares in Q1 2026, an estimated $35.4K.
- Simplex Trading first reported a position in AngioDynamics in Q4 2014 and held it in 18 quarters.
- Simplex Trading's AngioDynamics position peaked at $100K in Q2 2025.
- 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.